drugset / Trial / NCT03127618
Summary
Lorlatinib expanded access program
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Lorlatinib | Small molecule | — | — |
Indications
No indication recorded.
Lorlatinib expanded access program
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Lorlatinib | Small molecule | — | — |
No indication recorded.